chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Hyperhidrosis, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; 100.6 fever; Chills; Sweats; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route in the right arm on 13Apr2021 at 13:30 (at the age of 45-year-old) as single dose for COVID-19 immunisation. Medical history included HPV (human papilloma virus) oncogenic type 16/18 and severe dysplasia in pelvic areas. Concomitant medications included paracetamol (TYLENOL EXTRA STRENGTH), dextrin (BENEFIBER) and multivitamin (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received codeine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route in the right arm on 19Mar2021 at 13:30 (at the age of 45-year-old) as single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. On 13Apr2021 at 20:30 hours, the patient experienced sore arm, 100.6 fever, chills and sweats. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of sore arm, 100.6 fever, chills and sweats were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Tinnitus
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 10:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 00:00, the patient experienced headache, pain in arm and increased tinnitus. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of headache, pain in arm and increased tinnitus were recovering at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen Lymph node in armpit.; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Apr2021 at 09:00 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced swollen lymph node in the armpit. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event swollen lymph node in the armpit was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Experience chills on the next day after administration of 2nd dose; This is a spontaneous report from a contactable non-healthcare professional. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 13Apr2021 at 13:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history. It was unknown if the patient had any known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included paracetamol (TYLENOL), mefenamic acid (ADVIL), multivitamin and probiotic (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 23Mar2021 at 14:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 10:00, the patient experienced chills on the next day after administration of 2nd dose. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills was not recovered at time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Discomfort, Erythema, Pruritus, Purpura
Clinical narrative: discomfort and itching; Diffused purpuric rash on both legs; Erythema; Discomfort; This is a spontaneous report from a non-contactable healthcare professional. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via intramuscular route of administration in the right arm on 05Apr2021 at 12:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication was not reported. The patient underwent blood test to monitor platelet count and the result was normal limits. On an unknown date in Apr2021, the patient experienced diffused purpuric rash on both legs, erythema, discomfort and itching. The clinical outcome of the event purpuric rash, erythema, discomfort and itching was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Bruxism, Chills, Dehydration, Diarrhoea, Fatigue
Clinical narrative: severe diarrhea; achy/chills that night; achy/chills that night; fatigued and severe headache for two days (had to miss work); fatigued and severe headache for two days (had to miss work); fatigued and severe headache for two days (had to miss work); not sleep on the third night; dehydrated; gritting of teeth to the point of having a headache; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and Expiration Date was not reported) via an unspecified route of administration in left arm on 10Apr2021 14:45 as dose 1, single for COVID-19 immunization (at the age of 52-year-old, non-pregnant). Medical history included PMDD, allergies from cipro, tequin, seasonal and other allergies like ingredients in makeup, patient had COVID-19 prior vaccination. Patient received unspecified concomitant medications in two weeks. Patient had not tested covid post vaccination. The patient experienced severe diarrhea a few hours after vaccine, achy/chills that night, fatigued and severe headache for two days (had to miss work), felt like dehydrated on third day even though constantly drinking water/gatorade, gritting of teeth to the point of having a headache and not sleep on the third night on 10Apr2021 20:00. Patient did not receive any treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired work ability, Insomnia, Pain
Clinical narrative: severe diarrhea; achy/chills that night; achy/chills that night; fatigued and severe headache for two days (had to miss work); fatigued and severe headache for two days (had to miss work); fatigued and severe headache for two days (had to miss work); not sleep on the third night; dehydrated; gritting of teeth to the point of having a headache; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and Expiration Date was not reported) via an unspecified route of administration in left arm on 10Apr2021 14:45 as dose 1, single for COVID-19 immunization (at the age of 52-year-old, non-pregnant). Medical history included PMDD, allergies from cipro, tequin, seasonal and other allergies like ingredients in makeup, patient had COVID-19 prior vaccination. Patient received unspecified concomitant medications in two weeks. Patient had not tested covid post vaccination. The patient experienced severe diarrhea a few hours after vaccine, achy/chills that night, fatigued and severe headache for two days (had to miss work), felt like dehydrated on third day even though constantly drinking water/gatorade, gritting of teeth to the point of having a headache and not sleep on the third night on 10Apr2021 20:00. Patient did not receive any treatment for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headache; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 13Apr2021 at 08:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 23Mar2021 at 09:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, at 00:00 the patient experienced headache and exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as the result of adverse events.  The clinical outcome of the events headache and exhaustion were recovering at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; Chills; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to shrimp. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:00, the day after the vaccination, the patient experienced fever, chills and body aches and wanted to sleep. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) on 06Apr2021. The clinical outcome of the events fever, chills and body aches were resolving at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Nausea, Vertigo
Clinical narrative: Dizziness; Nausea; Vertigo; Motion Discomfort; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history was not and concomitant medications were not reported. The patient previously took Morphine and experienced drug allergy. The patient previously received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) in the left arm on 15Mar2021 at 13:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 06:00 the patient experienced dizziness, nausea, vertigo and motion discomfort. No therapeutic measures were taken as a result of the events. The  events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness, nausea, vertigo and motion discomfort was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Paraesthesia oral, Throat tightness
Clinical narrative: top lip suddenly began to tingle and looked puffy; top lip suddenly began to tingle and looked puffy; throat also felt like it was being squeezed on the outside; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 09:15(at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously took Neosporin(topical cream) on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient  receive other (unspecified) vaccines within four weeks prior to the vaccination. On 14Apr2021 at 09:50 within 35 minutes of the vaccine, while the patient was driving home the patient experienced top lip suddenly began to tingle and looked puffy and throat also felt like it was being squeezed on the outside and the patient pulled into a parking lot across from the nearest hospital emergency room to see if it was getting worse and it didn't so the patient drove 5 mins to home and then took 3 Benadryl, it was very scary. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with Benadryl. The clinical outcome of the events top lip suddenly began to tingle and looked puffy and throat also felt like it was being squeezed on the outside were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Tiredness; Headache; Fever up to 101.3; Chills; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Apr2021 at 14:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient did not receive any concomitant medication. The patient had no known allergies. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 08:45 (18 hours after receiving the vaccine), the patient experienced fever up to 101.3 and chills, which lasted for 24 hours. On 12Apr2021 at 13:00, the patient experienced tiredness and headache, which lasted more than 48 hours. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were taken as a result of events fever up to 101.3 (unspecified unit), chills, tiredness and headache and included treatment with homeopathic (herbal teas), vitamin c and advair from an unknown date. The clinical outcome of the event fever up to 101.3 and chills was recovered on 13Apr2021 after the duration of 1 day. The clinical outcome of the event tiredness and headache was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Muscle spasms, SARS-CoV-2 test
Clinical narrative: Painful continuous spasms in left sacro iliac region; Painful continuous spasms in left sacro iliac region; This is a spontaneous report from a contactable consumer, the patient. A 81-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Mar2021 (at the age of 81-year-old) as a single dose for COVID-19 immunisation. Medical history included osteoarthritis lower spine, cancer. Concomitant medications included ramipril (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and pravastatin (MANUFACTURER UNKNOWN) all started from unknown dates and for unspecified indication. The patient had known allergy to sulfa drugs. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 26Feb2021 (at the age of 81-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021, at 04:00, two days after second dose, the patient experienced painful continuous spasms in left sarco-iliac region of back lasted all day and declined in severity over next few days. On the day of report, almost after 4 weeks of vaccination, the area was still painfully sore. On 01Apr2021, the patient underwent Nasal Swab COVID-19 virus test and the results were found to be negative. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events.  The clinical outcome of the event's painful continuous spasms in left sarco-iliac region of back was recovering with sequelae.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus bilaterally since 1st dose,; This is a spontaneous report from a non-contactable healthcare professional. A 59-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration on 24Mar2021(at the age of 59-year-old) as a single dose for COVID-19immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, unknown if  the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021 the patient experienced tinnitus bilaterally since 1st dose. No therapeutic measures were taken for the reported events. The clinical outcome of the event tinnitus bilaterally since 1st dose, was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Burning sensation, Chills, Discomfort, Dry eye
Clinical narrative: general unwell feeling; brain fog; fatigue; occasional shortness of breath; fast heart that comes & goes,; sore muscles; bad leg pains; calf cramps/leg cramp; headaches; chills; night sweats; heavy; tingly/burning/prickly pins/needlessensation in legs, feet, hands,forearms,; /burning/prickly pins/needlessensation in legs, feet, hands,forearms; tight calf muscles; stuffy nose; pain at injection site; extremely dry eyes; extremely puffy eyes; red flushed face, neck,and chest; red flushed face, neck,and chest,; stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergy. Concomitant medications included levocetirizine dihydrochloride (XYZAL), fluticasone propionate (FLONASE), famotidine (PEPCID), vitamins nos (MANUFACTURER UNKNOWN), ethinylestradiol; ferrous fumarate; norethisterone acetate (LO LOESTRIN FE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 11:45 the patient experienced tight calf muscles, stuffy nose, pain at injection site. On 31Mar2021, the patient experienced extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache. On 01Apr2021, the patient experienced general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats. On an unknown date in Apr2021, the patient experienced heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps, occasional shortness of breath and fast heart that comes and goes, stuffy nose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tight calf muscles, stuffy nose, pain at injection site, extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache, general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats, heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps was unknown.   No follow-up attempts are needed. No further information is expected
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Erythema, Fatigue, Feeling abnormal, Flushing
Clinical narrative: general unwell feeling; brain fog; fatigue; occasional shortness of breath; fast heart that comes & goes,; sore muscles; bad leg pains; calf cramps/leg cramp; headaches; chills; night sweats; heavy; tingly/burning/prickly pins/needlessensation in legs, feet, hands,forearms,; /burning/prickly pins/needlessensation in legs, feet, hands,forearms; tight calf muscles; stuffy nose; pain at injection site; extremely dry eyes; extremely puffy eyes; red flushed face, neck,and chest; red flushed face, neck,and chest,; stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergy. Concomitant medications included levocetirizine dihydrochloride (XYZAL), fluticasone propionate (FLONASE), famotidine (PEPCID), vitamins nos (MANUFACTURER UNKNOWN), ethinylestradiol; ferrous fumarate; norethisterone acetate (LO LOESTRIN FE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 11:45 the patient experienced tight calf muscles, stuffy nose, pain at injection site. On 31Mar2021, the patient experienced extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache. On 01Apr2021, the patient experienced general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats. On an unknown date in Apr2021, the patient experienced heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps, occasional shortness of breath and fast heart that comes and goes, stuffy nose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tight calf muscles, stuffy nose, pain at injection site, extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache, general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats, heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps was unknown.   No follow-up attempts are needed. No further information is expected
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Malaise, Muscle spasms, Muscle tightness
Clinical narrative: general unwell feeling; brain fog; fatigue; occasional shortness of breath; fast heart that comes & goes,; sore muscles; bad leg pains; calf cramps/leg cramp; headaches; chills; night sweats; heavy; tingly/burning/prickly pins/needlessensation in legs, feet, hands,forearms,; /burning/prickly pins/needlessensation in legs, feet, hands,forearms; tight calf muscles; stuffy nose; pain at injection site; extremely dry eyes; extremely puffy eyes; red flushed face, neck,and chest; red flushed face, neck,and chest,; stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergy. Concomitant medications included levocetirizine dihydrochloride (XYZAL), fluticasone propionate (FLONASE), famotidine (PEPCID), vitamins nos (MANUFACTURER UNKNOWN), ethinylestradiol; ferrous fumarate; norethisterone acetate (LO LOESTRIN FE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 11:45 the patient experienced tight calf muscles, stuffy nose, pain at injection site. On 31Mar2021, the patient experienced extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache. On 01Apr2021, the patient experienced general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats. On an unknown date in Apr2021, the patient experienced heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps, occasional shortness of breath and fast heart that comes and goes, stuffy nose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tight calf muscles, stuffy nose, pain at injection site, extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache, general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats, heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps was unknown.   No follow-up attempts are needed. No further information is expected
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Night sweats, Pain in extremity, Paraesthesia
Clinical narrative: general unwell feeling; brain fog; fatigue; occasional shortness of breath; fast heart that comes & goes,; sore muscles; bad leg pains; calf cramps/leg cramp; headaches; chills; night sweats; heavy; tingly/burning/prickly pins/needlessensation in legs, feet, hands,forearms,; /burning/prickly pins/needlessensation in legs, feet, hands,forearms; tight calf muscles; stuffy nose; pain at injection site; extremely dry eyes; extremely puffy eyes; red flushed face, neck,and chest; red flushed face, neck,and chest,; stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergy. Concomitant medications included levocetirizine dihydrochloride (XYZAL), fluticasone propionate (FLONASE), famotidine (PEPCID), vitamins nos (MANUFACTURER UNKNOWN), ethinylestradiol; ferrous fumarate; norethisterone acetate (LO LOESTRIN FE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 11:45 the patient experienced tight calf muscles, stuffy nose, pain at injection site. On 31Mar2021, the patient experienced extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache. On 01Apr2021, the patient experienced general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats. On an unknown date in Apr2021, the patient experienced heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps, occasional shortness of breath and fast heart that comes and goes, stuffy nose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tight calf muscles, stuffy nose, pain at injection site, extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache, general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats, heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps was unknown.   No follow-up attempts are needed. No further information is expected
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Periorbital swelling, Vaccination site pain
Clinical narrative: general unwell feeling; brain fog; fatigue; occasional shortness of breath; fast heart that comes & goes,; sore muscles; bad leg pains; calf cramps/leg cramp; headaches; chills; night sweats; heavy; tingly/burning/prickly pins/needlessensation in legs, feet, hands,forearms,; /burning/prickly pins/needlessensation in legs, feet, hands,forearms; tight calf muscles; stuffy nose; pain at injection site; extremely dry eyes; extremely puffy eyes; red flushed face, neck,and chest; red flushed face, neck,and chest,; stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergy. Concomitant medications included levocetirizine dihydrochloride (XYZAL), fluticasone propionate (FLONASE), famotidine (PEPCID), vitamins nos (MANUFACTURER UNKNOWN), ethinylestradiol; ferrous fumarate; norethisterone acetate (LO LOESTRIN FE) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 11:45 the patient experienced tight calf muscles, stuffy nose, pain at injection site. On 31Mar2021, the patient experienced extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache. On 01Apr2021, the patient experienced general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats. On an unknown date in Apr2021, the patient experienced heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps, occasional shortness of breath and fast heart that comes and goes, stuffy nose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tight calf muscles, stuffy nose, pain at injection site, extremely dry puffy eyes, red flushed face, neck, and chest, and stomach ache, general unwell feeling, brain fog, fatigue/exhaustion, occasional shortness of breath and fast heart that comes & goes, sore muscles, bad leg pains and calf cramps; bad headaches, stuffy nose, chills, night sweats, heavy, tingly/burning/prickly pins/needles sensation in legs, feet, hands, forearms, bad leg pains and cramps was unknown.   No follow-up attempts are needed. No further information is expected
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Shingles-type pain on head; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, vestibular issues, fibromyalgia. The patient had known allergies to sulfa. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) of 5 mg, mirtazapine (MANUFACTURER UNKNOWN) of 10 mg and cyclobenzaprine (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 02Apr2021 at 21:30, the patient experienced shingles-type pain on head. Since the vaccination, the patient had not been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were not taken as a result of reported event. The clinical outcome of the event shingles-type pain on head was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site rash
Clinical narrative: Rash at injection sight, spreading down the arm and shoulder blade; Rash at injection sight, spreading down the arm and shoulder blade; Very itchy; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERO0734) via an unspecified route of administration in the right arm on 05Apr2021 at 16:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient previously took penicillin and experienced penicillin allergy. Concomitant medications taken within two weeks of vaccination included metoprolol (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and simvastatin (SIM); all from unknown date and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 15Mar2021 at 16:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 15:15, the patient experienced rash at injection sight, spreading down the arm and shoulder blade. Very itchy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events rash at injection sight, spreading down the arm and shoulder blade and very itchy was not resolved at the time of this report . No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: fingers on left hand tingled.; This is a spontaneous report from a contactable consumer. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 06Apr2021 at 11:45 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, cholesterol and smoker. The patient had no allergy to medications, food, or other products. Concomitant medications included losartan potassium (LOSARTIN) from an unknown date and unknown if ongoing for an unknown indication. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced fingers on left hand tingled for days. It was reported that the worst day three days after and subsided after a week. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event fingers on left hand tingled was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Mass
Clinical narrative: Swollen lump on left collar bone; This is a spontaneous report from a contactable nurse, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 at 11:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 11:00, the patient experienced swollen lump on left collar bone. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event swollen lump on left collar bone was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Pain in extremity
Clinical narrative: Horrible migraine; nausea; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263) via an unspecified route of administration in left arm on 26Feb2021 at 11:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported.  Concomitant medications were not reported. The patient had a drug allergy to amoxicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Feb2021 at 17:00, the patient had experienced horrible migraine, nausea and sore arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. The clinical outcome of the events, horrible migraine, nausea and sore arm was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neck pain, Pain, Pain in extremity
Clinical narrative: Left arm pit lymph nodes extremely swollen and pain is almost unbearable.; Pain is all the way around my left arm and up into my neck and clavicle area; Pain is all the way around my left arm and up into my neck and clavicle area; Pain is all the way around my left arm and up into my neck and clavicle area; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP3784) via an unspecified route of administration in the left arm on 12Apr2021(at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient did not have any known allergies to medications, food, or other products. Concomitant medications included vitamin b complex (B COMPLEX) and fish oil (MANUFACTURER UNKNOWN); both for unspecified indication and start date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 18:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 15:30, the patient experienced left arm pit lymph nodes extremely swollen and pain was almost unbearable. Pain was all the way around the left arm and up into the neck and clavicle area. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient received any treatment for the events. The clinical outcome of the event left arm pit lymph nodes extremely swollen and pain was almost unbearable, pain was all the way around left arm and up into neck and clavicle area was not recovered, at this time of this report.  No follow-up attempts are needed. No further information is expected.